Related Experiment Videos
[Bilateral papillary edema associated to immunotherapy]
Cédric Orban1, Maxime Dequinze1
1Service d'Ophtalmologie, CHR Citadelle, Liège, Belgique.
Revue Medicale De Liege
|August 3, 2026
Summary
Combined immunotherapy improves outcomes for metastatic melanoma but can cause side effects. This case highlights a severe visual impairment due to papillary edema, a rare complication of this treatment.
Area of Science:
- Oncology
- Ophthalmology
- Immunology
Background:
- Immunotherapy is a leading treatment for metastatic melanoma, significantly improving patient prognosis.
- Despite its efficacy, immunotherapy is associated with various specific and multisystemic side effects.
- Ocular side effects of immunotherapy, though less common, can lead to significant morbidity.